Valuation : Abbott Laboratories

Market Cap 195B 168B 157B 144B 270B 18,600B 271B 1,865B 728B 9,389B 731B 715B 31,133B P/E 2026 *
32.3x
P/E 2027 * 24.9x
Enterprise Value 219B 188B 177B 161B 304B 20,888B 305B 2,095B 817B 10,544B 821B 803B 34,963B EV / Sales 2026 *
4.34x
EV / Sales 2027 * 3.94x
Free-Float
86.16%
Yield 2026 *
2.29%
Yield 2027 * 2.44%
1 day+0.79%
1 week-3.58%
Current month+6.40%
1 month+4.85%
3 months+30.32%
6 months-3.33%
Current year-10.23%
1 week 111.11
Extreme 111.11
117.34
1 month 102.89
Extreme 102.89
117.34
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap.
25/8/26 Fiscal year

Chief Executive Officer

1,196,496 0.0691%
12/8/26 Other

EXECUTIVE VICE PRESIDENT

-12 0.0000%
30/6/26 Free

Director

416 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.79%-3.58%-14.39%+9.42% 195B
+1.40%-2.27%-0.79%+12.09% 117B
+0.25%+1.25%+11.09%+78.52% 61.45B
-0.25%-1.97%+26.78%+53.11% 51.03B
+0.74%-1.29%-0.90%-32.69% 51.62B
+1.71%-1.65%+20.96%-8.53% 34.27B
+1.82%+2.98% - - 30.95B
-2.49%-4.42%+37.49%-16.34% 23.75B
-0.82%-1.17%-4.66%+18.23% 23.41B
+0.35%-1.74%-4.49%+2.61% 22.79B
Average +0.35%-1.10%+7.90%+12.94% 61.07B
Weighted average by Cap. +0.66%-1.84%+0.87%+15.35%

Financials

2026 *2027 *
Net sales 50.3B 43.35B 40.64B 37.1B 69.89B 4,808B 70.11B 482B 188B 2,427B 189B 185B 8,047B 54.65B 47.09B 44.15B 40.3B 75.92B 5,223B 76.17B 524B 204B 2,636B 205B 201B 8,742B
Net income 6.23B 5.37B 5.04B 4.6B 8.66B 596B 8.69B 59.74B 23.31B 301B 23.4B 22.89B 997B 7.92B 6.83B 6.4B 5.84B 11.01B 757B 11.05B 75.96B 29.64B 382B 29.75B 29.1B 1,268B
Net Debt 23.94B 20.63B 19.34B 17.66B 33.26B 2,288B 33.37B 229B 89.53B 1,155B 89.88B 87.92B 3,830B 20.96B 18.06B 16.93B 15.46B 29.12B 2,003B 29.21B 201B 78.38B 1,011B 78.68B 76.97B 3,353B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
28/08/26 USD 112.47 +0.79% 7,545,112
27/08/26 USD 111.59 -2.20% 8,355,172
26/08/26 USD 114.10 -1.75% 6,959,229
25/08/26 USD 116.13 -0.46% 7,503,742
24/08/26 USD 116.67 +0.03% 5,917,080
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
112.47USD
Average target price
120.20USD
Spread / Average Target
+6.87%

Quarterly revenue - Rate of surprise